Hims & Hers' shift to branded obesity drugs drives wider quarterly loss - Reuters
Hims & Hers' shift to branded obesity drugs drives wider quarterly loss Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNZE9uc3FFWEtxcEs0azRvZmRNSmctTXVZb0dGMFBvN25Oc1ExVWE4cWxPWWFNdGczX1V6dDFjS0JMSksyUXJ2NW4zRmhWck5ubWwxNEtyUi0xc2R0MGpCMjVTeHRXMHRfZC1TVFhYQzBPYVc0a0FGdkxQVm8tMVBwMHJqS0JGRGdtbWR1dTFVd1YxSWdvdUNkdjhoYlZrYUpweUsyekRNVDNBREdybXlobVY1OWFKM0pTTXc?oc=5" target="_blank">Hims & Hers' shift to branded obesity drugs drives wider quarterly loss</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMAs Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters
August 12, 2026 at 06:34 PMTarget lifts annual forecasts again as Fiddelke's turnaround takes root - Reuters
Target lifts annual forecasts again as Fiddelke's turnaround takes root Reuters
August 19, 2026 at 01:56 PMIce cream makers bet consumers still want treats, just healthier ones - Reuters
Ice cream makers bet consumers still want treats, just healthier ones Reuters
August 13, 2026 at 06:27 AMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PM